Lord Glitters! RESPECT!
Thank You Barons! -
MyTheresa stock might be cheapest thing it sells, Barron's says 12:01 MYTE Mytheresa stock - technically an American depositary share of parent company MYT Netherlands Parent - was recently trading just below its $26 initial-public-offering price after having jumped to $36 shortly after the debut, Nicholas Jasinski writes in this week's edition of Barron's. The stock could recover those losses and more in the coming months, the author contends, noting that while luxury buyer might have been slower to adopt e-commerce, the overall luxury market is growing by about 7% annually.
Oh My! Yes!
Mytheresa initiated with a Buy at Jefferies 02/16 MYTE Jefferies analyst Flavio Cereda initiated coverage of Mytheresa with a Buy rating and $37 price target. The company is "the only pure Luxury multibrand digital platform currently listed" on the NYSE in a a segment of the sector that has "high barriers to entry and is a de facto oligopoly," Cereda tells investors. He sees Mytheresa being set to deliver compound annual revenue growth of 20%+ with "stable margins," Cereda added.
MYTE Tomorrow's Gummy Today!
Thank You Barons! -
MyTheresa stock might be cheapest thing it sells, Barron's says 12:01 MYTE Mytheresa stock - technically an American depositary share of parent company MYT Netherlands Parent - was recently trading just below its $26 initial-public-offering price after having jumped to $36 shortly after the debut, Nicholas Jasinski writes in this week's edition of Barron's. The stock could recover those losses and more in the coming months, the author contends, noting that while luxury buyer might have been slower to adopt e-commerce, the overall luxury market is growing by about 7% annually.
Oh My! Yes!
Mytheresa initiated with a Buy at Jefferies 02/16 MYTE Jefferies analyst Flavio Cereda initiated coverage of Mytheresa with a Buy rating and $37 price target. The company is "the only pure Luxury multibrand digital platform currently listed" on the NYSE in a a segment of the sector that has "high barriers to entry and is a de facto oligopoly," Cereda tells investors. He sees Mytheresa being set to deliver compound annual revenue growth of 20%+ with "stable margins," Cereda added.
MYTE Tomorrow's Gummy Today!

